RECRUITING

Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.

Official Title

Identifying Modifiable PAtient Centered Therapeutics Frailty: an Observational Cohort Study

Quick Facts

Study Start:2023-09-22
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04717869

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients admitted to the Surgical, Cardiothoracic or Neuro ICU
  2. * ICU stay longer than 24 hours
  1. * Patients with muscular or mitochondrial diseases affecting muscle quality or mass
  2. * Preexisting paralysis
  3. * Absence of lower limbs
  4. * Ongoing discussions about goals of care
  5. * Transfers from a skilled nursing facility
  6. * Children under the age of 18

Contacts and Locations

Study Contact

Jennifer Scovotti, MA
CONTACT
3102064484
jscovotti@mednet.ucla.edu

Principal Investigator

Cecilia Canales, MD, MPH
PRINCIPAL_INVESTIGATOR
UCLA Department of Anesthesiology and Perioperative Medicine

Study Locations (Sites)

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Cecilia Canales, MD, MPH, PRINCIPAL_INVESTIGATOR, UCLA Department of Anesthesiology and Perioperative Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-22
Study Completion Date2026-07

Study Record Updates

Study Start Date2023-09-22
Study Completion Date2026-07

Terms related to this study

Keywords Provided by Researchers

  • Frailty
  • Sarcopenia
  • Ultrasound

Additional Relevant MeSH Terms

  • Frailty
  • Sarcopenia